MINODIAB

This brand name is authorized in Spain, Mexico, United Kingdom

Active ingredients

The drug MINODIAB contains one active pharmaceutical ingredient (API):

1 Glipizide UNII X7WDT95N5C - GLIPIZIDE

Glipizide is an oral blood-glucose-lowering drug of the sulfonylurea class. The primary mode of action of glipizide is the stimulation of insulin secretion from the beta-cells of pancreatic islet tissue. Read about Glipizide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MINODIAB Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BB07	Glipizide	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BB Sulfonamides, urea derivatives
Discover more medicines within A10BB07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 51293
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 20527
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 79341